Max Healthcare Institute Limited (MAXHEALTH) — Financial Results | 16 November 2025

· NSE 🔴 High Importance ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Max Healthcare reported consolidated revenue of ₹2,13,547 lakhs for Q2 FY2026, up 25% YoY from ₹1,70,746 lakhs. Consolidated net profit surged 74.3% to ₹49,130 lakhs from ₹28,181 lakhs YoY, benefiting from a ₹7,899 lakh tax reversal following NCLT approval of subsidiary merger on November 7, 2025. Half-year consolidated revenue reached ₹4,16,304 lakhs versus ₹3,25,041 lakhs YoY. The company divested two UP hospitals for ₹4,066 lakhs in September 2025.

📄 View Original Announcement (PDF)

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MAXHEALTH — Free

Free account · 2 AI queries/day